Nicolas Doulet
Adjoint au business development & communication, OTR3
Ph.D in microbiology with an advanced master's degree in the management of innovation in biotechnologies at Masternova, I worked for 3 years at Orphanet as a project manager, responsible for the data in preclinical research in the field of rare diseases, and at France Biotech for the implementation of the Panorama 2007 of the French biotech industry.
I have recently joined OTR3 ( www.otr3.com ), a French biotech company focused on wound healing and matrix therapy, as the business development and communication manager.
Do not hesitate to contact me if you have any questions, I would be happy to help you. If you have any information which can help me, I would be most grateful to contact me at:
nicolas.doulet@gmail.com
Best regards,
Nicolas Doulet
Specialities:
Business development, knowledge and data management, communication, rare diseases, health, biotechnology
296 contactsOTR3 is a French biotech company developing solutions for wound healing by matrix therapy. Two products are already marketed Cacipliq20 for chronic wound healing and Cacicol20 for ocular ulcers.
For further information, do not hesitate to contact me or to visit our website at: www.otr3.com
2008 - 2011Orphanet ( www.orpha.net ) is a reference free-access portal offering information on rare diseases and orphan drugs. We provide specific information to connect innovative fundamental research, medicine and private industry.
I am in charge of treating data on rare diseases European networks, patient registries, licensing opportunities and research projects, including the selection of projects with partnership potential, and of the coordination of Orphanet partners.
2007 - 2007France Biotech is the French association of biotechnology companies and partners. Its mission is to help to raise the French biotechnology industry to a leading position in Europe.
During a period of six months, I was in charge of the realisation of the Panorama study 2007 of the French biotech industry.